Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3084519 | 0.81 | SCD (0.53) | SCD | |
| SCHEMBL3086094 | 0.81 | SCD (0.55) | SCD | |
| SCHEMBL3079906 | 0.81 | SCD (0.54) | SCD | |
| SCHEMBL3093624 | 0.80 | SCD (0.57) | SCD | |
| SCHEMBL1811939 | 0.79 | SCD (0.57) | SCD | |
| SCHEMBL3097745 | 0.78 | SCD (0.69) | SCD | |
| SCHEMBL3104029 | 0.77 | SCD (0.52) | SCD | |
| SCHEMBL1816387 | 0.76 | SCD (0.54) | SCD | |
| SCHEMBL936566 | 0.74 | SCD (0.59) | SCD | |
| SCHEMBL1814039 | 0.74 | SCD (0.67) | SCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7799787-B2 | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase | MERCK FROSST CANADA LTD. (CA) | 2010-09-21 | — | — | US | disclosed |
| US-7799787-B2 | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase | MERCK FROSST CANADA LTD. (CA) | 2010-09-21 | — | — | US | disclosed |
| US-7799787-B2 | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase | MERCK FROSST CANADA LTD. (CA) | 2010-09-21 | — | — | US | disclosed |
| US-20090088431-A1 | Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | MERCK FROSST CANADA LTD. | 2009-04-02 | — | — | US | disclosed |
| US-20090088431-A1 | Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | MERCK FROSST CANADA LTD. | 2009-04-02 | — | — | US | disclosed |
| US-20090088431-A1 | Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | MERCK FROSST CANADA LTD. | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088431-A1 | Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | SCD, SCD5, SREBF1 | SCD 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.